CSIMarket
 
Biocryst Pharmaceuticals Inc   (BCRX)
 

News




Biocryst Pharmaceutical*s Inducement Grants and Impact on Company Shares

Unveiling the Impact of ORLADEYO on Reducing HAE Attack Rates: New Real-World Data Shows Promising Results

BioCryst Pharmaceuticals Expands Access and Advances Pipeline of Innovative Therapies

BioCryst Pharmaceuticals, Inc. Grants Stock Options and RSUs as Inducements to Newly-Hired Employees Under Nasdaq Listing Rule 5635(c)(4)

BioCryst*s ORLADEYO Achieves Remarkable Growth, Forecasts Accelerated Path to Profitability

BioCryst Pharmaceuticals Grants Inducement Stock Options and RSUs, Bolstering Workforce and Aligning Employee Interests with Company*s Growth Trajectory

ORLADEYO: A Game-Changer in the Treatment of Hereditary Angioedema

BioCryst Pharmaceuticals Grants Stock Options and RSUs to Newly-Hired Employees, Strengthening Shareholder Value

BioCryst Pharmaceuticals Triumphs with Approval of ORLADEYO in Argentina, Offering a New Hope for Hereditary Angioedema (HAE) Patients

BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months

BioCryst Pharmaceuticals Inc. Achieves Impressive Double-Digit Top-Line Growth in Fourth Quarter of 2023

Biocryst Pharmaceuticals Inc Smashes Expectations with Remarkable Fading Deficit in Q3 Fiscal Period 2023

Biocryst Pharmaceuticals Inc Fails to Attain Profitability Despite Revenue Boost during Q2 2023

Biocryst Pharmaceuticals Inc: Despite Revenue Surge, the Company Fails to Turn Profitable in Fiscal Period Ending March 31, 2023

Compelling quarter by Biocryst Pharmaceuticals Inc all along the fiscal fourth quarter of 2022

The company disclosed the loss has been reduced remarkably, in the July to September 30 2022 period









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com